Literature DB >> 32291751

Treatment of severe cutaneous adverse reaction with tocilizumab.

B P Hibler1, A Markova1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32291751      PMCID： PMC7541614          DOI： 10.1111/bjd.19129

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  8 in total

1.  Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.

Authors:  Chuang-Wei Wang; Lan-Yan Yang; Chun-Bing Chen; Hsin-Chun Ho; Shuen-Iu Hung; Chih-Hsun Yang; Chee-Jen Chang; Shih-Chi Su; Rosaline Chung-Yee Hui; See-Wen Chin; Li-Fang Huang; Yang Yu-Wei Lin; Wei-Yang Chang; Wen-Lang Fan; Chin-Yi Yang; Ji-Chen Ho; Ya-Ching Chang; Chun-Wei Lu; Wen-Hung Chung
Journal:  J Clin Invest       Date:  2018-02-05       Impact factor: 14.808

Review 2.  Antibiotic allergy.

Authors:  Kimberly G Blumenthal; Jonny G Peter; Jason A Trubiano; Elizabeth J Phillips
Journal:  Lancet       Date:  2018-12-14       Impact factor: 79.321

Review 3.  Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.

Authors:  Xin Yao; Jiaqi Huang; Haihong Zhong; Nan Shen; Raffaella Faggioni; Michael Fung; Yihong Yao
Journal:  Pharmacol Ther       Date:  2013-09-27       Impact factor: 12.310

Review 4.  Monitoring the acute response in severe hypersensitivity reactions to drugs.

Authors:  Tetsuo Shiohara; Yoshiko Mizukawa; Yumi Aoyama
Journal:  Curr Opin Allergy Clin Immunol       Date:  2015-08

5.  Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.

Authors:  Marco L Davila; Isabelle Riviere; Xiuyan Wang; Shirley Bartido; Jae Park; Kevin Curran; Stephen S Chung; Jolanta Stefanski; Oriana Borquez-Ojeda; Malgorzata Olszewska; Jinrong Qu; Teresa Wasielewska; Qing He; Mitsu Fink; Himaly Shinglot; Maher Youssif; Mark Satter; Yongzeng Wang; James Hosey; Hilda Quintanilla; Elizabeth Halton; Yvette Bernal; Diana C G Bouhassira; Maria E Arcila; Mithat Gonen; Gail J Roboz; Peter Maslak; Dan Douer; Mark G Frattini; Sergio Giralt; Michel Sadelain; Renier Brentjens
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

Review 6.  Interleukin 6: from bench to bedside.

Authors:  Norihiro Nishimoto; Tadamitsu Kishimoto
Journal:  Nat Clin Pract Rheumatol       Date:  2006-11

Review 7.  Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.

Authors:  Chun-Bing Chen; Ming-Ying Wu; Chau Yee Ng; Chun-Wei Lu; Jennifer Wu; Pei-Han Kao; Chan-Keng Yang; Meng-Ting Peng; Chen-Yang Huang; Wen-Cheng Chang; Rosaline Chung-Yee Hui; Chih-Hsun Yang; Shun-Fa Yang; Wen-Hung Chung; Shih-Chi Su
Journal:  Cancer Manag Res       Date:  2018-05-17       Impact factor: 3.989

8.  Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study.

Authors:  Akbar K Waljee; Mary A M Rogers; Paul Lin; Amit G Singal; Joshua D Stein; Rory M Marks; John Z Ayanian; Brahmajee K Nallamothu
Journal:  BMJ       Date:  2017-04-12
  8 in total
  2 in total

Review 1.  High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer.

Authors:  Alyce M Kuo; Alina Markova
Journal:  Front Med (Lausanne)       Date:  2022-06-13

Review 2.  Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?

Authors:  Mikhail Kiselevskiy; Irina Shubina; Irina Chikileva; Suria Sitdikova; Igor Samoylenko; Natalia Anisimova; Kirill Kirgizov; Amina Suleimanova; Tatyana Gorbunova; Svetlana Varfolomeeva
Journal:  Pharmaceuticals (Basel)       Date:  2020-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.